The Latest Updates from SAA

When TNF inhibitor medications fail in spondyloarthritis

Posted January 2017

Biologic medications, such as TNF inhibitors (TNFi) and IL-17 inhibitors (IL-17i), are the current standard in rheumatologic treatment of moderate to severe spondyloarthritis. But what happens when patients don’t respond to this class of medications?

Read more…

Clinical Trial Opportunity

Posted January 2017

The following is an announcement from SAA about a third party clinical trial. SAA is not affiliated with this study, the researchers, or the drug manufacturer.

Read more…

The AbbVie Immunology Scholarship

Posted December 2016

AbbVie is giving away 45 college scholarships of $15,000 each to U.S. residents living with inflammatory diseases.

Read more…

Nonradiographic Axial Spondyloarthritis: The Case for Early TNF-i Interventions in Axial SpA

Posted December 2016

Esteemed rheumatologist and researcher, Atul Deodhar, M.D., M.R.C.P. discusses his new axial spondyloarthritis study, which concludes in supporting TNF inhibitor use in nonradiographic axial spondyloarthritis.

Read more…

Help: I Don’t Have Health Insurance!

Posted December 2016

What you can do if you are suffering but don’t have health insurance and can’t afford to see a doctor or get treatment.

Read more…
RSS
12345678910Last

Stay Informed

Contact Us

Spondylitis Association of America

PO Box 5872
Sherman Oaks, CA 91413

Email

info@spondylitis.org

Toll Free Hotline

(800) 777-8189 U.S. only
or (818) 892-1616

Give With Confidence